Patent US4835187A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4835187A Expired / Lapsed US ⏱️ 0.0 years remaining

Spray dried ibuprofen

Assignee: Wyeth LLC
•
Filing: 1987-06-15
•
Granted: 1989-05-30
•
Expires: 2007-06-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A therapeutic taste-neutral powder form a ibuprofen obtained by spray-drying a suspension of colloidal silica in a lower alkanol solution of ibuprofen and a cellulose material such as ethyl cellulose, hydroxyethyl cellulose and hydroxypropylmethyl cellulose.

Inventors

  • 👤 Gerald L. Reuter
  • 👤 Maureen M. Harrison

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 00:10
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/14; A61K9/16; A61K9/1605; A61K9/1617; A61K31/00; A61K31/185; A61K31/19; A61K9/0012; A61K9/0053; A61K9/0056; A61K9/1611; A61K9/1629; A61K9/1652

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 93 words
A therapeutic taste neutral powder form of spray-dried ibuprofen which consists essentially of, based upon the weight of the powder, about 40% to 70% by weight ibuprofen, about 15% to 50% by weight of a cellulose material selected from the class consisting of ethylcellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose and admixtures thereof and about 5% to 40% by weight colloidal silica, the powder having been spray dried from a suspension of the colloidal silica in a lower alkanol solution of the ibuprofen and the cellulose material, the lower alkanol containing up to 50% water.
Claim 2
Dependent Claim 93 words
A therapeutic taste neutral powder form of spray-dried ibuprofen which consists essentially of, based upon the weight of the powder, about 40% to 70% by weight ibuprofen, about 15% to 50% by weight of a cellulose material selected from the class consisting of ethylcellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose and admixtures thereof and about 5% to 40% by weight colloidal silica, the powder having been spray dried from a suspension of the colloidal silica in a lower alkanol solution of the ibuprofen and the cellulose material, the lower alkanol containing up to 50% water.
Claim 3
Dependent Claim 127 words
In a pharmaceutical dosage form for oral administration as a solid, which dosage form can be distinguished by water within ten seconds, the improvement which comprises incorporating into such dosage form as the pharmaceutical substance a therapeutic taste-neutral powder form of spray-dried ibuprofen which consists essentially of, based upon the weight of the powder, about 40% to 70% by weight ibuprofen, about 15% to 50% by weight of a cellulose material selected from the class consisting of ethylcellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose and admixtures thereof and about 5% to 40% by weight colloidal silica, the powder having been spray dried from a suspension of the colloidal silica in a lower alkanol solution of the ibuprofen and the cellulose material, the lower alkanol containing up to 50% water.
Claim 4
Dependent Claim 127 words
In a pharmaceutical dosage form for oral administration as a solid, which dosage form can be distinguished by water within ten seconds, the improvement which comprises incorporating into such dosage form as the pharmaceutical substance a therapeutic taste-neutral powder form of spray-dried ibuprofen which consists essentially of, based upon the weight of the powder, about 40% to 70% by weight ibuprofen, about 15% to 50% by weight of a cellulose material selected from the class consisting of ethylcellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose and admixtures thereof and about 5% to 40% by weight colloidal silica, the powder having been spray dried from a suspension of the colloidal silica in a lower alkanol solution of the ibuprofen and the cellulose material, the lower alkanol containing up to 50% water.
Claim 5
Dependent Claim 14 words
The taste neutral powder of claim 1 wherein the lower alkanol is isopropyl alcohol.
Claim 6
Dependent Claim 14 words
The taste neutral powder of claim 2 wherein the lower alkanol is isopropyl alcohol.
Claim 7
Dependent Claim 118 words
In a pharmaceutical dosage form for oral administration as a solid chewable taste-neutral tablet containing ibuprofen, the improvement which comprises incorporating into such tablet as the pharmaceutical substance a therapeutic taste-neutral powder form of spray-dried ibuprofen which consists essentially of, based upon the weight of the powder, about 40% to 70% ibuprofen, about 15% to 50% by weight of a cellulose material selected from the class consisting of ethylcellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose and admixtures thereof, and about 5% to 40% by weight colloidal silica, the powder having been spray dried from a suspension of the colloidal silica in a lower alkanol solution of the ibuprofen and the cellulose material, the lower alkanol containing up to 50% water.
Claim 8
Dependent Claim 118 words
In a pharmaceutical dosage form for oral administration as a solid chewable taste-neutral tablet containing ibuprofen, the improvement which comprises incorporating into such tablet as the pharmaceutical substance a therapeutic taste-neutral powder form of spray-dried ibuprofen which consists essentially of, based upon the weight of the powder, about 40% to 70% ibuprofen, about 15% to 50% by weight of a cellulose material selected from the class consisting of ethylcellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose and admixtures thereof, and about 5% to 40% by weight colloidal silica, the powder having been spray dried from a suspension of the colloidal silica in a lower alkanol solution of the ibuprofen and the cellulose material, the lower alkanol containing up to 50% water.
Claim 9
Dependent Claim 13 words
The dosage form of claim 3 wherein the lower alkanol is isopropyl alcohol.
Claim 10
Dependent Claim 13 words
The taste neutral powder of claim 1 wherein the cellulose is hydroxyethyl cellulose.
Claim 11
Dependent Claim 12 words
The dosage form of claim 2 wherein the cellulose is hydroxyethyl cellulose.
Claim 12
Dependent Claim 12 words
The dosage form of claim 3 wherein the cellulose is hydroxyethyl cellulose.

References Cited (Backward Citations)

US4713249A Cited
US4681897A Cited
US4690823A Cited
US4571400A Cited
EP0190826A2 Cited
US4569937A Cited
US4695591A Cited
US4689218A Cited
US4726966A Cited
US4684666A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-05-29 1992-11-28 1993-05-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-05-29 1996-11-28 1997-05-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-05-29 2000-11-28 2001-05-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag